Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients

Journal of Surgical Oncology

Volumn 100, Issue 4, 2009, Pages 331-334

  Valle, M ^a   Van Der Speeten, K ^b   Garofalo, A ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Chemotherapy; Intraperitoneal; Laparoscopy; Malignant ascites

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN;

ADULT; AGED; ASCITES TUMOR; CANCER MORTALITY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; INTRAOPERATIVE PERIOD; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIMARY TUMOR; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCITES; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 69749109618     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21321     Document Type: Conference Paper

References (43)

1. Tamsma J: The pathogenesis of malignant ascites. Cancer Treat Res 2007;134:109-118.
2. Adam RA, Adam YG: Malignant ascites: Past, present and future. J Am Coll Surg 2004;198:999-1011. (Pubitemid 38759851)
3. Sako A, Kitayama J, Shida D, et al.: Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites. J Surg Res 2006;130:94-101. (Pubitemid 43028570)
4. Nagy JA, Morgan ES, Herzberg KT, et al.: Pathogenesis of ascites tumour growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res 1995;55:376-385.
5. Coates G, Bush RS, Aspin N: A study of ascites using lymphoscintigraphy with 99m Tc-sulfur colloid. Radiology 1973;107:577-583.
6. Garrison RN, Kaelin LD, Galloway RH, et al.: Malignant ascites. Clinical and experimental observations. Ann Surg 1986;203:644-651.
7. Shen-Gunther J, Mannel RD: Ascites as a predictor of ovarian malignancy. Gynecol Oncol 2002;87:77-83.
8. Ringenberg QS, Doll DC, Loy TS, et al.: Malignant ascites of unknown origin. Cancer 1989;64:753-755.
9. Easson AM, Bezjak A, Ross S, et al.: The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites. Ann Surg Oncol 2007;14:2348-2357. (Pubitemid 47174909)
10. Becker G, Galandi D, Blum HE: Malignant ascites: Systematic review and guideline for treatment. Eur J Cancer 2006;42:589-597. (Pubitemid 43343680)
11. Lee CW, Bociek G, Faught W: A survey of practice in management of malignant ascites. J Pain Symptom Manage 1998;16:96-101. (Pubitemid 28400159)
12. Ariel IM, Oropeza R, Pack GT: Intracavitary administration of radioactive isotopes in the control of effusions due to cancer. Results in 267 patients. Cancer 1966;19:1096-1102.
13. Leveen HH, Christoudias G, Ip M, et al.: Peritoneo-venous shunts for ascites. Ann Surg 1974;180:580-591.
14. Oosterlee J: Peritoneovenous shunts for ascites in cancer patients. Br J Surg 1980;67:663-666. (Pubitemid 11226624)
15. Xu L, Yoneda J, Herrera C, et al.: Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Int J Oncol 2000;16:445-454.
16. Parsons SL, Watson SA, Steele RJ: Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites. Eur J Surg Oncol 1997;23:526-531.
17. Katano M, Morisaki T: The past, the present and future of the OK-432 therapy for patients with malignant effusions. Anticancer Res 1998;18:3917-3925. (Pubitemid 28561081)
18. Verwaal VJ, Van Ruth S, De Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743. (Pubitemid 46606227)
19. Glehen O, Mithieux F, Osinsky D, et al.: Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 2003;21:799-806. (Pubitemid 46606438)
20. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004;22:3284-3292. (Pubitemid 41103684)
21. Yan TD, Black D, Sugarbaker PH, et al.: A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007;14:2702-2713. (Pubitemid 47460649)
22. Bijelic L, Jonson A, Sugarbaker PH: Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 2007;18:1943-1950. (Pubitemid 350286229)
23. Yan TD, Welch L, Black D, et al.: A systematic review of the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 2007;18:827-834. (Pubitemid 47054078)
24. Yan TD, Black D, Savady R, et al.: A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Oncol 2007;14:484-492. (Pubitemid 46175292)
25. Yan TD, Black D, Savady R, et al.: Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006;24:4011-4019. (Pubitemid 46630752)
26. Garofalo A, Valle M, Garcia J, et al.: Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol 2006;32:682-685. (Pubitemid 44064001)
27. Facchiano E, Scaringi S, Kianmanesh R, et al.: Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol 2007;34:154-158.
28. Patriti A, Cavazzoni E, Graziosi L, et al.: Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy. Surg Laparosc Endosc Percutan Tech 2008;18:426-428.
29. Kim HJ, D'Angelica M, Hiotis SP, et al.: Laparoscopic staging for liver, biliary, pancreas, and gastric cancer. Curr Probl Surg 2007;44:228-269. (Pubitemid 46647988)
30. Jerby BL, Milsom JW: Role of laparoscopy in the staging of gastrointestinal cancer. Oncology 1998;12:1353-1360. (Pubitemid 128617935)
31. Feussner H, Härtl F: Staging laparoscopy in oncology. Chirurg 2006;77:971-980.
32. Garofalo A, Valle M: Staging videolaparoscopy of peritoneal carcinomatosis. Tumori 2003;89:70-77.
33. Valle M, Garofalo A: Laparoscopic staging of peritoneal surface malignancies. Eur J Surg Oncol 2006;32:625-627. (Pubitemid 44064002)
34. Fagotti A, Ferradina G, Fanfani F, et al.: Prospective validation of laparoscopic predictive model for optimal cytoreduction in advanced ovarian cancer. Am J Obstet Gynecol 2008 [Epub ahead of print].
35. Pomel C, Appleyard TL, Gouy S, et al.: The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005;31:540-543. (Pubitemid 40724096)
36. Hager ED, Dziambor H, Höhmann D, et al.: Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy resistant peritoneal disseminated ovarian cancer. Int J Gynecol Cancer 2001;11:57-63. (Pubitemid 32751387)
37. Link KH, Roitman M, Holtappels M, et al.: Intraperitoneal chemotherapy with mitoxantrone in malignant ascites. Surg Oncol Clin North Am 2003;12:865-872. (Pubitemid 36920105)
38. Chang E, Alexander HR, Libutti SK, et al.: Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg 2001;193:225-229. (Pubitemid 32729627)
39. Esquis P, Consolo D, Magnin G, et al.: High intraabdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental carcinomatosis. Ann Surg 2006;244:106-112. (Pubitemid 44297454)
40. Jacquet P, Stuart OA, Chang D, et al.: Effect of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs 1996;7:596-603. (Pubitemid 26276352)
41. Gesson-Paute A, Ferron G, Thomas F, et al.: Pharmacokinetics of oxaliplatin during open versus laparoscopic assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): An experimental study. Ann Surg Oncol 2008;15:339-344.
42. Thomas F, Ferron G, Gesson-Paute A, et al.: Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008 [Epub ahead of print].
43. Ozols RF, Young RC, Speyer JL, et al.: Phase I study and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 1982;42:4265-4269.